NASDAQ:ATHA
Athira Pharma, Inc. Stock News
$2.62
+0.0900 (+3.56%)
At Close: May 31, 2024
Athira Class Action Reminder
09:50pm, Friday, 09'th Jul 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
NEW YORK, July 9, 2021 /PRNewswire/ -- WHY: , Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athira Pharma, Inc. (NASDAQ: ATHA): (a) pursuant and/or traceab
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)
02:00pm, Friday, 09'th Jul 2021
LOS ANGELES, July 9, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming August 24, 2021 deadline to file a lead plaintiff motion in the class action filed on
SHAREHOLDER ALERT: Robbins LLP Announces that Athira Pharma, Inc. (ATHA) is Being Sued for Misleading Shareholders
12:24pm, Friday, 09'th Jul 2021
SAN DIEGO & BOTHELL, Wash.--(BUSINESS WIRE)---- $ATHA #ATHA--Shareholder rights law firm Robbins LLP announces that several class actions have been filed on behalf of all purchasers of Athira Pharma,
Los Angeles, California--(Newsfile Corp. - July 9, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, Inc
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 24, 2021 to f
San Francisco, California--(Newsfile Corp. - July 8, 2021) - Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now. A securities class ac
New York, New York--(Newsfile Corp. - July 8, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Athira Pharma, Inc. ("Athira " or "the Co
Los Angeles, California--(Newsfile Corp. - July 8, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, Inc
Athira Shareholder Alert
09:46pm, Wednesday, 07'th Jul 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
PHILADELPHIA and CLEVELAND, July 7, 2021 /PRNewswire/ -- The investor rights attorneys at Goldman Scarlato & Penny, PC law firm ("GSP") are evaluating potential claims for compensation on behalf of in
Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds ATHA Investors for Securities Fraud Class Action Lawsuit
06:22pm, Tuesday, 06'th Jul 2021
RADNOR, Pa., July 6, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that securities fraud class action lawsuits have been filed against Athira Pharma, Inc. (
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Athira Pharma, Inc. ("Athira " or "the Company
Athira Pharma Starts Open-Label Extension Of Alzheimer's Disease Trials
09:09am, Tuesday, 06'th Jul 2021
Athira Pharma Inc (NASDAQ: ATHA) has started enrollment in an open-label extension (OLEX) study for its ongoing Phase 2/3 LIFT-AD and Phase 2 ACT-AD studies of ATH-1017 for the treatment of mild-to
Study Extension allows for additional 26 weeks of treatment on ATH-1017 Study Extension allows for additional 26 weeks of treatment on ATH-1017
